Cancer innovation advances in many ways, but real impact depends on the ability to translate progress into care that is ...
Protean Small Cap fell 0.9% in March, outperforming its benchmark's 3.1% decline. Read the full analysis for more details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results